Literature DB >> 20585129

Depolarization, bacterial membrane composition, and the antimicrobial action of ceragenins.

Raquel F Epand1, Jake E Pollard, Jonathan O Wright, Paul B Savage, Richard M Epand.   

Abstract

Ceragenins are cholic acid-derived antimicrobial agents that mimic the activity of endogenous antimicrobial peptides. Ceragenins target bacterial membranes, yet the consequences of these interactions have not been fully elucidated. The role of the outer membrane in allowing access of the ceragenins to the cytoplasmic membrane of gram-negative bacteria was studied using the ML-35p mutant strain of Escherichia coli that has been engineered to allow independent monitoring of small-molecule flux across the inner and outer membranes. The ceragenins CSA-8, CSA-13, and CSA-54 permeabilize the outer membrane of this bacterium, suggesting that the outer membrane does not play a major role in preventing the access of these agents to the cytoplasmic membrane. However, only the most potent of these ceragenins, CSA-13, was able to permeabilize the inner membrane. Interestingly, neither CSA-8 nor CSA-54 caused inner membrane permeabilization over a 30-min period, even at concentrations well above those required for bacterial toxicity. To further assess the role of membrane interactions, we measured membrane depolarization in gram-positive bacteria with different membrane lipid compositions, as well as in gram-negative bacteria. We found greatly increased membrane depolarization at the minimal bactericidal concentration of the ceragenins for bacterial species containing a high concentration of phosphatidylethanolamine or uncharged lipids in their cytoplasmic membranes. Although membrane lipid composition affected bactericidal efficiency, membrane depolarization was sufficient to cause lethality, providing that agents could access the cytoplasmic membrane. Consequently, we propose that in targeting bacterial cytoplasmic membranes, focus be placed on membrane depolarization as an indicator of potency.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20585129      PMCID: PMC2934994          DOI: 10.1128/AAC.00380-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Correlation of the antibacterial activities of cationic peptide antibiotics and cationic steroid antibiotics.

Authors:  Bangwei Ding; Qunying Guan; Joshua P Walsh; J Scott Boswell; Tim W Winter; Erica S Winter; Stephanie S Boyd; Chunhong Li; Paul B Savage
Journal:  J Med Chem       Date:  2002-01-31       Impact factor: 7.446

2.  Self-assembly of influenza hemagglutinin: studies of ectodomain aggregation by in situ atomic force microscopy.

Authors:  R F Epand; C M Yip; L V Chernomordik; D L LeDuc; Y K Shin; R M Epand
Journal:  Biochim Biophys Acta       Date:  2001-08-06

3.  Antibacterial activity and specificity of the six human {alpha}-defensins.

Authors:  Bryan Ericksen; Zhibin Wu; Wuyuan Lu; Robert I Lehrer
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

4.  Concurrent assessment of inner and outer membrane permeabilization and bacteriolysis in E. coli by multiple-wavelength spectrophotometry.

Authors:  R I Lehrer; A Barton; T Ganz
Journal:  J Immunol Methods       Date:  1988-04-06       Impact factor: 2.303

5.  Structure-function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteria.

Authors:  H Tsubery; I Ofek; S Cohen; M Fridkin
Journal:  J Med Chem       Date:  2000-08-10       Impact factor: 7.446

6.  A molecular mechanism for lipopolysaccharide protection of Gram-negative bacteria from antimicrobial peptides.

Authors:  Niv Papo; Yechiel Shai
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

7.  Lipid clustering by three homologous arginine-rich antimicrobial peptides is insensitive to amino acid arrangement and induced secondary structure.

Authors:  Richard M Epand; Raquel F Epand; Christopher J Arnusch; Brigitte Papahadjopoulos-Sternberg; Guangshun Wang; Yechiel Shai
Journal:  Biochim Biophys Acta       Date:  2010-03-17

8.  Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic.

Authors:  E Breukink; I Wiedemann; C van Kraaij; O P Kuipers; H G Sahl; B de Kruijff
Journal:  Science       Date:  1999-12-17       Impact factor: 47.728

9.  Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity.

Authors:  R I Lehrer; A Barton; K A Daher; S S Harwig; T Ganz; M E Selsted
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

10.  Phosphatidylkojibiosyl diglyceride. The covalently linked lipid constituent of the membrane lipoteichoic acid from Streptococcus faecalis (faecium) ATCC 9790.

Authors:  M C Ganfield; R A Pieringer
Journal:  J Biol Chem       Date:  1975-01-25       Impact factor: 5.157

View more
  55 in total

Review 1.  Topical antimicrobials for burn infections - an update.

Authors:  Mert Sevgi; Ani Toklu; Daniela Vecchio; Michael R Hamblin
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2013-12

2.  Structural insights into and activity analysis of the antimicrobial peptide myxinidin.

Authors:  Marco Cantisani; Emiliana Finamore; Eleonora Mignogna; Annarita Falanga; Giovanni Francesco Nicoletti; Carlo Pedone; Giancarlo Morelli; Marilisa Leone; Massimiliano Galdiero; Stefania Galdiero
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

3.  Membrane activity profiling of small molecule B. subtilis growth inhibitors utilizing novel duel-dye fluorescence assay.

Authors:  S McAuley; A Huynh; T L Czarny; E D Brown; J R Nodwell
Journal:  Medchemcomm       Date:  2018-02-15       Impact factor: 3.597

4.  Development of a broad spectrum polymer-released antimicrobial coating for the prevention of resistant strain bacterial infections.

Authors:  K D Sinclair; T X Pham; R W Farnsworth; D L Williams; C Loc-Carrillo; L A Horne; S H Ingebretsen; R D Bloebaum
Journal:  J Biomed Mater Res A       Date:  2012-05-24       Impact factor: 4.396

5.  Analysis of the flexibility and stability of the structure of magainin in a bilayer, and in aqueous and nonaqueous solutions using molecular dynamics simulations.

Authors:  Elham Esmaili; Mohsen Shahlaei
Journal:  J Mol Model       Date:  2015-03-08       Impact factor: 1.810

6.  New amphiphilic neamine derivatives active against resistant Pseudomonas aeruginosa and their interactions with lipopolysaccharides.

Authors:  Guillaume Sautrey; Louis Zimmermann; Magali Deleu; Alicia Delbar; Luiza Souza Machado; Katy Jeannot; Françoise Van Bambeke; Julien M Buyck; Jean-Luc Decout; Marie-Paule Mingeot-Leclercq
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

7.  In vitro efficacy of a novel active-release antimicrobial coating to eradicate biofilms of Pseudomonas aeruginosa.

Authors:  Dustin L Williams; Julia M Lerdahl; Bryan S Haymond; Roy D Bloebaum
Journal:  Antimicrob Agents Chemother       Date:  2014-01-06       Impact factor: 5.191

8.  Two distinct amphipathic peptide antibiotics with systemic efficacy.

Authors:  Jayaram Lakshmaiah Narayana; Biswajit Mishra; Tamara Lushnikova; Qianhui Wu; Yashpal S Chhonker; Yingxia Zhang; D Zarena; Evgeniy S Salnikov; Xiangli Dang; Fangyu Wang; Caitlin Murphy; Kirk W Foster; Santhi Gorantla; Burkhard Bechinger; Daryl J Murry; Guangshun Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-28       Impact factor: 11.205

9.  Towards the Prediction of Antimicrobial Efficacy for Hydrogen Bonded, Self-Associating Amphiphiles.

Authors:  Nyasha Allen; Lisa J White; Jessica E Boles; George T Williams; Dominique F Chu; Rebecca J Ellaby; Helena J Shepherd; Kendrick K L Ng; Laura R Blackholly; Ben Wilson; Daniel P Mulvihill; Jennifer R Hiscock
Journal:  ChemMedChem       Date:  2020-10-16       Impact factor: 3.466

Review 10.  High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.

Authors:  Guangshun Wang; Biswajit Mishra; Raquel F Epand; Richard M Epand
Journal:  Biochim Biophys Acta       Date:  2014-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.